Driving MCS Innovation: magAssist Engages Global Experts at ESAO 2025

From June 25–28, 2025, magAssist participated in the 51st Congress of the European Society for Artificial Organs (ESAO) in Enschede, Netherlands. The annual event gathered global experts in biomedical engineering, cardiology, and translational science to explore the latest advancements in artificial organ technology.

At the conference, magAssist presented its latest progress in mechanical circulatory support (MCS), including advancements in extracorporeal VAD, percutaneous VAD (pVAD), and ECMO systems. Highlights included:

• Pump drivetrain design for next-generation pVADs

• Modular platforms supporting multi-indication care

• Hemodynamic Support of a Foldable Pump in High-Risk PCI

• Flow Field Optimization in Oxygenator Design

• Integrative modeling frameworks for precision therapy and real-time optimization

Scientific Contributions from magAssist

The magAssist team was invited to deliver multiple presentations showcasing their latest research and innovations in mechanical circulatory support：

I-Fan Yen, VP of magAssist, presented two topics:

• “Integrative Modeling Framework for Mechanical Circulatory Support: Enabling Real-Time Hemodynamic Insights and Optimization”

• “Modular Integration in Mechanical Circulatory Support: A Unified Platform for Multi-Indication Care”

Dr. Chiahao Hsu, Senior Director of Science & Innovation of magAssist , shared insights into:

• “Drive Train Design for Advanced Percutaneous Ventricular Assist Devices: Insights from Engineering”

• “NyokAssist™ Percutaneous Transvalvular Ventricular Assist Device Performance in High-Risk Percutaneous Coronary Intervention”

Tingting Wu,  Scientist of magAssist delivered three technical presentations:

• “A Novel Oxygenator Optimization Methodology Mitigating Dual-Low Region”

• “Mechanical Circulatory Support for Ventricular Septal Defects: Simulation Using a Lumped-Parameter Model”

• “Expandable Percutaneous Micro-Axial Flow Blood Pumps: Techniques for Accurate Hydraulic Performance Measurement”

These presentations reflect magAssist's commitment to advancing translational MCS research and fostering data-driven therapy optimization.

Collaboration and Exchange

Beyond the academic program, the magAssist team engaged in valuable conversations with clinicians, researchers, and industry partners from Aachen and the broader MCS community. At the magAssist booth, they connected with international experts from both academia and clinical practice to exchange insights on clinical needs and discuss future directions in artificial organ technology.

About ESAO

The European Society for Artificial Organs(ESAO) , founded in 1974 in Geneva, is a leading international community dedicated to the advancement of artificial organ science and regenerative medicine. ESAO plays a key role in shaping the future of life-sustaining technologies, with a focus on cardiac assist devices, biomaterials, computational modeling, and tissue engineering.